CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology Conference
globenewswire.com
news
2022-10-20 00:00:00

BERKELEY HEIGHTS, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that an abstract has been accepted for presentation at the American Society of Nephrology (ASN) annual meeting being held in Orlando, Florida, November 3 â€“ 6. The abstract being presented highlights a retrospective analysis that was conducted integrating multiple clinical and claims databases that track kidney failure patients.
